{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:37:45Z","timestamp":1784259465959,"version":"3.55.0"},"reference-count":40,"publisher":"Touch Medical Media, Ltd.","issue":"2","license":[{"start":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"This article is published under the Creative Commons Attribution Non-commercial License."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"abstract":"<p>The American Diabetes Association and the European Association for the Study of Diabetes consensus statement 2022 effectively captures the changing paradigm of modern diabetes care. As emphasized in the guidelines, a person-centered decision cycle focusing on preventing complications and improving quality of life is the driving principle behind modern diabetes management. Other notable features of the document are its emphasis on self-management education, therapeutic behaviour, sleep hygiene, nonalcoholic fatty liver disease and weight loss. Focus on individualization of care, social determinants of health, and ethnic variations are pertinent from an Afro-Asian perspective. The \u201clanguage matters\u201d section is a welcome addition that will help to overcome several barriers in diabetes care.<\/p>","DOI":"10.17925\/ee.2023.19.2.1","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T09:46:28Z","timestamp":1687340788000},"page":"1","source":"Crossref","is-referenced-by-count":3,"title":["ADA\u2013EASD Consensus Report on the Management of Hyperglycaemia in Type 2 Diabetes in an Afro-Asian Context: Broadening the Perspective"],"prefix":"10.17925","volume":"19","author":[{"given":"Saptarshi","family":"Bhattacharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Endocrinology, Indraprastha Apollo Hospitals, New Delhi, India","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kalra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Endocrinology, Bharti Hospital, Karnal, India","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"University Center for Research & Development, Chandigarh University, Mohali, Punjab, India","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7274","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycemia in type 2 diabetesHyperglycemia in Type 2 Diabetes, 2022. A consensus reportConsensus Report by the American diabetes association Diabetes Association (ADA) and the European association for the study of diabetesAssociation for the Study of Diabetes (EASD).\n                      Diabetes Care\n                      . 2022;45:2753\u201386. DOI: 10.2337\/dci22-0034","DOI":"10.2337\/dci22-0034"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Peimani M, Nasli-Esfahani E, Sadeghi R. Patients\u2019 perceptions of patient-provider communication and diabetes care: Aa systematic review of quantitative and qualitative studies.\n                      Chronic Illn\n                      . 2020;16:3\u201322. DOI: 10.1177\/1742395318782378","DOI":"10.1177\/1742395318782378"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.\n                      Diabetes Res Clin Pract\n                      . 2022;183:109119. DOI: 10.1016\/j.diabres.2021.109119","DOI":"10.1016\/j.diabres.2021.109119"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Gujral UP, Pradeepa R, Weber MB, et al. Type 2 diabetes in South Asians: Ssimilarities and differences with white Caucasian and other populations.\n                      Ann N Y Acad Sci\n                      . 2013;1281:51\u201363. DOI: 10.1111\/j.1749-6632.2012.06838.x","DOI":"10.1111\/j.1749-6632.2012.06838.x"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Chan JCN, Malik V, Jia W, et al. Diabetes in Asia: Eepidemiology, risk factors, and pathophysiology.\n                      JAMA\n                      . 2009;301:2129\u201340. DOI: 10.1001\/jama.2009.726","DOI":"10.1001\/jama.2009.726"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Zhao D. Epidemiological features of cardiovascular disease in Asia.\n                      JACC Asia\n                      . 2021;1:1\u201313. DOI: 10.1016\/j.jacasi.2021.04.007","DOI":"10.1016\/j.jacasi.2021.04.007"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Minja NW, Nakagaayi D, Aliku T, et al. Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward.\n                      Front Cardiovasc Med\n                      . 2022;9:1008335. DOI: 10.3389\/fcvm.2022.1008335","DOI":"10.3389\/fcvm.2022.1008335"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Cao C, Hu H, Zheng X, et al. Association between central obesity and incident diabetes mellitus among Japanese: A retrospective cohort study using propensity score matching.\n                      Sci Rep\n                      . 2022;12:13445. DOI: 10.1038\/s41598-022-17837-1","DOI":"10.1038\/s41598-022-17837-1"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Indulekha K, Anjana RM, Surendar J, Mohan V. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113).\n                      Clin Biochem\n                      . 2011;44:281\u20137. DOI: 10.1016\/j.clinbiochem.2010.12.015","DOI":"10.1016\/j.clinbiochem.2010.12.015"},{"key":"ref10","unstructured":"Kapoor N. Thin fat obesity: The tropical phenotype of obesity. In: Feingold KR, Anawalt B, Boyce A, (eds).\n                      Endotext\n                      . MDText.com, Inc, 2000. Available at: www.ncbi.nlm.nih.gov\/books\/NBK568563\/ (accessed date: 12 January 2023)"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Sattar N, Welsh P, Leslie WS, et al. Dietary weight-management for type 2 diabetes remissions in South Asians: The South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby).\n                      Lancet Reg Health Southeast Asia\n                      . 2023;9:100111. DOI: 10.1016\/j.lansea.2022.100111","DOI":"10.1016\/j.lansea.2022.100111"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Blonde L, Umpierrez GE, Reddy SS, et al. American association of clinical endocrinology clinical practice guideline: D developing a diabetes mellitus comprehensive care plan-2022 update.\n                      Endocr Pract\n                      . 2022;28:923\u20131049. DOI: 10.1016\/j.eprac.2022.08.002","DOI":"10.1016\/j.eprac.2022.08.002"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Lee MMY, Ghouri N, McGuire DK, et al. Meta-analyses of results from randomized outcome trials comparing cardiovascular effects of SGLT2is and GLP-1RAs in Asian versus white patients with and without type 2 diabetes.\n                      Diabetes Care\n                      . 2021;44:1236\u201341. DOI: 10.2337\/dc20-3007","DOI":"10.2337\/dc20-3007"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Diallo A, Carlos-Bolumbu M, Galtier F. Age, sex, race, BMI, and duration of diabetes differences in cardiovascular outcomes with glucose lowering drugs in type 2 diabetes: Aa systematic review and meta-analysis.\n                      EClinicalMedicine\n                      . 2022;54:101697. DOI: 10.1016\/j.eclinm.2022.101697","DOI":"10.1016\/j.eclinm.2022.101697"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Fr\u00edas JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once wWeekly in patients with type 2 diabetes.\n                      N Engl J Med\n                      . 2021;385:503\u201315. DOI: 10.1056\/NEJMoa2107519","DOI":"10.1056\/NEJMoa2107519"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Kalra S, Bahendeka S, Sahay R, et al. Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of type 2 diabetes mellitus \u2013 International task force.\n                      Indian J Endocrinol Metab\n                      . 2018;22:132\u201357. DOI: 10.4103\/ijem.IJEM_556_17","DOI":"10.4103\/ijem.IJEM_22_18"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Lim L-L, Lau ESH, Cheung JTK, et al. Real-world usage of sulphonylureas in Asian patients with type 2 diabetes using the joint Asia diabetes evaluation (JADE) register.\n                      Diabetes Obes Metab\n                      . 2023;25:208\u201321. DOI: 10.1111\/dom.14865","DOI":"10.1111\/dom.14865"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Gu S, Shi L, Shao H, et al. Choice across 10 pharmacologic combination strategies for type 2 diabetes: A cost-effectiveness analysis.\n                      BMC Med\n                      . 2020;18:378. DOI: 10.1186\/s12916-020-01837-x","DOI":"10.1186\/s12916-020-01837-x"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Chien CL, Chen YC, Malone DC, et al. Cost-utility analysis of second-line anti-diabetic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin.\n                      Curr Med Res Opin\n                      . 2020;36:1619\u201326. DOI: 10.1080\/03007995.2020.1815686","DOI":"10.1080\/03007995.2020.1815686"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Permsuwan U, Dilokthornsakul P, Thavorn K, et al. Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand.\n                      J Med Econ\n                      . 2017;20:171\u201381. DOI: 10.1080\/13696998.2016.1238386","DOI":"10.1080\/13696998.2016.1238386"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Nguyen-Thi HY, Nguyen NT, Le NDT, et al. Cost-eEffectiveness of gliclazide-based intensive glucose control vs. standard glucose control in type 2 diabetes mellitus. An economic analysis of the advance trial in Vietnam.\n                      Front Public Health\n                      . 2020;8:562023. DOI: 10.3389\/fpubh.2020.562023","DOI":"10.3389\/fpubh.2020.562023"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Huang S, Shi K, Ren Y, et al. Association of magnitude of weight loss and weight variability with mortality and major cardiovascular events among individuals with type 2 diabetes mellitus: Aa systematic review and meta-analysis.\n                      Cardiovasc Diabetol\n                      . 2022;21:78. DOI: 10.1186\/s12933-022-01503-x","DOI":"10.1186\/s12933-022-01503-x"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Moazzeni SS, Hizomi Arani R, Deravi N, et al. Weight change and risk of cardiovascular disease among adults with type 2 diabetes: More than 14 years of follow-up in the Tehran lipid and glucose study.\n                      Cardiovasc Diabetol\n                      . 2021;20:141. DOI: 10.1186\/s12933-021-01326-2","DOI":"10.1186\/s12933-021-01326-2"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: Aa systematic literature review of scientific evidence from across the world in 2007-2017.\n                      Cardiovasc Diabetol\n                      . 2018;17:83. DOI: 10.1186\/s12933-018-0728-6","DOI":"10.1186\/s12933-018-0728-6"},{"key":"ref25","unstructured":"Gheith O, Farouk N, Nampoory N, et al. Diabetic kidney disease: Wworld wide difference of prevalence and risk factors.\n                      J Nephropharmacol\n                      . 2016;5:49\u201356."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Dunachie S, Chamnan P. The double burden of diabetes and global infection in low and middle-income countries.\n                      Trans R Soc Trop Med Hyg\n                      . 2019;113:56\u201364. DOI: 10.1093\/trstmh\/try124","DOI":"10.1093\/trstmh\/try124"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"van Crevel R, van de Vijver S, Moore DAJ. The global diabetes epidemic: Wwhat does it mean for infectious diseases in tropical countries?\n                      Lancet Diabetes Endocrinol\n                      . 2017;5:457\u201368. DOI: 10.1016\/S2213-8587(16)30081-X","DOI":"10.1016\/S2213-8587(16)30081-X"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Jiang W, Xu X, Tang S, et al. Inequity in healthcare needs, health service use and financial burden of medical expenditures in China: Rresults from a consecutive household monitoring study in Jiangsu Province.\n                      BMC Health Serv Res\n                      . 2019;19:966. DOI: 10.1186\/s12913-019-4796-4","DOI":"10.1186\/s12913-019-4796-4"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Carapinha JL, Ross-Degnan D, Desta AT, Wagner AK. Health insurance systems in five sub-Saharan African countries: Mmedicine benefits and data for decision making.\n                      Health Policy\n                      . 2011;99:193\u2013202. DOI: 10.1016\/j.healthpol.2010.11.009","DOI":"10.1016\/j.healthpol.2010.11.009"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Du W, Liu P, Xu W. Effects of decreasing the out-of-pocket expenses for outpatient care on health-seeking behaviors, health outcomes and medical expenses of people with diabetes: Eevidence from China.\n                      Int J Equity Health\n                      . 2022;21:162. DOI: 10.1186\/s12939-022-01775-5","DOI":"10.1186\/s12939-022-01775-5"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Moucheraud C, Lenz C, Latkovic M, Wirtz VJ. The costs of diabetes treatment in low- and middle-income countries: A systematic review.\n                      BMJ Glob Health\n                      . 2019;4:e001258. DOI: 10.1136\/bmjgh-2018-001258","DOI":"10.1136\/bmjgh-2018-001258"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes.\n                      N Engl J Med\n                      . 2008;359:1577\u201389. DOI: 10.1056\/NEJMoa0806470","DOI":"10.1056\/NEJMoa0806470"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Dutta D, Bhattacharya S, Sharma M, et al. Effect of yoga on glycemia and lipid parameters in type-2 diabetes: A meta-analysis.\n                      J Diabetes Metab Disord\n                      . 2021;20:349\u201367. DOI: 10.1007\/s40200-021-00751-0","DOI":"10.1007\/s40200-021-00751-0"},{"key":"ref34","unstructured":"Redmer J, Longmier E, Wedel P. Targeting diabetes: The benefits of an integrative approach.\n                      J Fam Pract\n                      . 2013;62:337\u201344."},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Priya G, Kalra S. Mind-body interactions and mindfulness meditation in diabetes.\n                      Eur Endocrinol\n                      . 2018;14:35\u201341. DOI: 10.17925\/EE.2018.14.1.35","DOI":"10.17925\/EE.2018.14.1.35"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Onyishi CN, Ilechukwu LC, Victor-Aigbodion V, Eseadi C. Impact of spiritual beliefs and faith-based interventions on diabetes management.\n                      World J Diabetes\n                      . 2021;12:630\u201341. DOI: 10.4239\/wjd.v12.i5.630","DOI":"10.4239\/wjd.v12.i5.630"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Li X, Si H, Chen Y, et al. Effects of fitness qigong and tai chi on middle-aged and elderly patients with type 2 diabetes mellitus.\n                      PLoS One\n                      . 2020;15:e0243989. DOI: 10.1371\/journal.pone.0243989","DOI":"10.1371\/journal.pone.0243989"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Yang Q, Shao Q, Xu Q, et al. Art therapy alleviates the levels of depression and blood glucose in diabetic patients: Aa systematic review and meta-analysis.\n                      Front Psychol\n                      . 2021;12:639626. DOI: 10.3389\/fpsyg.2021.639626","DOI":"10.3389\/fpsyg.2021.639626"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Salmani Mood M, Yavari Z, Bahrami Taghanaki H, Mahmoudirad G. The effect of acupressure on fasting blood glucose, glycosylated hemoglobin and stress in patients with type 2 diabetes.\n                      Complement Ther Clin Pract\n                      . 2021;43:101393. DOI: 10.1016\/j.ctcp.2021.101393","DOI":"10.1016\/j.ctcp.2021.101393"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Setiyorini E, Qomaruddin MB, Wibisono S, et al. Complementary and alternative medicine for glycemic control of diabetes mellitus: Aa systematic review.\n                      J Public Health Res\n                      . 2022;11:22799036221106582. DOI: 10.1177\/22799036221106582","DOI":"10.1177\/22799036221106582"}],"container-title":["European Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/touchendocrinology.com\/diabetes\/journal-articles\/ada-easd-consensus-report-on-the-management-of-hyperglycaemia-in-type-2-diabetes-in-an-afro-asian-context-broadening-the-perspective\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:59:28Z","timestamp":1764745168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.touchendocrinology.com\/diabetes\/journal-articles\/ada-easd-consensus-report-on-the-management-of-hyperglycaemia-in-type-2-diabetes-in-an-afro-asian-context-broadening-the-perspective\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"alternative-id":["EE.2023.19.2.1"],"URL":"https:\/\/doi.org\/10.17925\/ee.2023.19.2.1","relation":{},"ISSN":["1758-3772"],"issn-type":[{"value":"1758-3772","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}